We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-4.17%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$68.3B
AUM Growth
-$3.23B
(-4.5%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
15.18%
Holding
779
New
72
Increased
344
Reduced
301
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$374M |
| 2 |
FirstEnergy
FE
|
+$348M |
| 3 |
Allstate
ALL
|
+$267M |
| 4 |
Sanofi
SNY
|
+$259M |
| 5 |
JPMorgan Chase
JPM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$603M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 3 |
Novartis
NVS
|
+$233M |
| 4 |
KLA
KLAC
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$207M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Healthcare | 17.72% |
| 3 | Industrials | 14.6% |
| 4 | Technology | 13.23% |
| 5 | Energy | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
American Eagle Outfitters
AEO
$2.98B
| $6.75M | 0.01% |
683,004
-19,634
| -3% | -$228K |
|
377
V2X
VVX
$2.73B
| $6.59M | 0.01% |
186,240
+61,924
| +50% | +$2.15M |
|
378
CBIZ
CBZ
$2.39B
| $6.11M | 0.01% |
142,915
-4,605
| -3% | -$201K |
|
379
Jefferies Financial Group
JEF
$13B
| $6.03M | 0.01% |
211,357
+141,541
| +203% | +$4.28M |
|
380
Walmart Inc
WMT
$889B
| $5.97M | 0.01% |
137,991
+1,008
| +0.7% | +$44.2K |
|
381
GrafTech
EAF
$203M
| $5.96M | 0.01% |
134,444
-77,524
| -37% | -$4.93M |
|
382
Thermo Fisher Scientific
TMO
$208B
| $5.82M | 0.01% |
11,477
-4,254
| -27% | -$2.38M |
|
383
Vanguard Extended Market ETF
VXF
$30.5B
| $5.8M | 0.01% |
+42,003
| New | +$5.92M |
|
384
Peapack-Gladstone Financial
PGC
$833M
| $5.74M | 0.01% |
+154,683
| New | +$5.09M |
|
385
Carriage Services
CSV
$635M
| $5.5M | 0.01% |
171,115
+30,588
| +22% | +$1.14M |
|
386
Rambus
RMBS
$10.4B
| $5.47M | 0.01% |
215,064
+81,744
| +61% | +$2.04M |
|
|
POSH
387
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $5.38M | 0.01% |
343,425
+164,059
| +91% | +$1.95M |
|
388
Pacira BioSciences
PCRX
$1.04B
| $5.35M | 0.01% |
100,589
+56,282
| +127% | +$3.13M |
|
389
W.R. Berkley
WRB
$28.1B
| $5.05M | 0.01% |
114,668
+25,985
| +29% | +$1.13M |
|
|
TA
390
DELISTED
TravelCenters of America LLC
TA
| $4.96M | 0.01% |
91,931
-2,930
| -3% | -$146K |
|
391
Skyworks Solutions
SWKS
$9.54B
| $4.93M | 0.01% |
+57,758
| New | +$5.91M |
|
392
Western Union
WU
$2.55B
| $4.9M | 0.01% |
363,043
-68,862
| -16% | -$1.08M |
|
|
LHCG
393
DELISTED
LHC Group LLC
LHCG
| $4.85M | 0.01% |
29,660
-953
| -3% | -$155K |
|
394
Jones Lang LaSalle
JLL
$15.5B
| $4.79M | 0.01% |
31,502
-1,271
| -4% | -$221K |
|
|
UNVR
395
DELISTED
Univar Solutions Inc.
UNVR
| $4.74M | 0.01% |
208,482
+88,621
| +74% | +$2.23M |
|
396
Amdocs
DOX
$5.64B
| $4.71M | 0.01% |
59,230
+5,684
| +11% | +$481K |
|
397
Kraft Heinz
KHC
$31.1B
| $4.63M | 0.01% |
138,876
+1,006
| +0.7% | +$37.4K |
|
398
Tronox
TROX
$973M
| $4.58M | 0.01% |
373,919
+158,271
| +73% | +$2.35M |
|
399
AGNC Investment
AGNC
$12.4B
| $4.46M | 0.01% |
530,329
-32,584
| -6% | -$383K |
|
400
SM Energy
SM
$7.26B
| $4.42M | 0.01% |
117,611
+57,517
| +96% | +$2.26M |
|
Similar funds
Boston Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Boston Partners held 779 positions worth $68.3B, down 4.5% from $71.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q3 2022 filing shows 72 new, 344 increased, 301 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 8,800,892 shares worth $326M. The largest sale was Procter & Gamble, an estimated $603M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q3 2022 buy was FirstEnergy: 8,800,892 shares worth $326M.
- Boston Partners added most to Bristol-Myers Squibb in Q3 2022, an estimated $374M increase.
- Boston Partners's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $561M.
- Boston Partners fully exited Procter & Gamble in Q3 2022, selling an estimated $603M.
- Boston Partners's ten largest holdings make up 15% of its $68.3B portfolio in Q3 2022.
- Boston Partners opened 72 new positions and closed 59 in Q3 2022.
- Boston Partners's portfolio value fell 4.5% quarter-over-quarter to $68.3B.
Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.